|
|
 Previous Article | Table of Contents | Next Article 
RAPID COMMUNICATION
A BCR-ABLp190 Fusion Gene Made by Homologous Recombination Causes B-Cell Acute Lymphoblastic Leukemias in Chimeric Mice With Independence of the Endogenous bcr Product
A. Castellanos,
B. Pintado,
E. Weruaga,
R. Arévalo,
A. López,
A. Orfao, and
I. Sánchez-García
From the Departamento de Proliferación y Diferenciación Celular, Instituto de Microbiología Bioquímica, Edificio Departamental, Salamanca, Spain; the Area de Reproducción Animal, Centro de Investigación y Tecnología, Madrid, Spain; and the Departamento de Biología Celular y Patología and Servicio de Citometría, Universidad de Salamanca, Salamanca, Spain.
BCR-ABLp190 oncogene is the result of a reciprocal translocation between chromosomes 9 and 22 and is associated with B-cell acute lymphoblastic leukemia (B-ALL) in humans. Current models expressing the BCR-ABLp190 chimeric gene fail to consistently reproduce the phenotype with which the fusion gene is associated in human pathology, mainly due to the difficulty of being expressed in the appropriate cell type in vivo. We have used here homologous recombination in ES cells to create an in-frame fusion of BCR-ABLp190 that mimics the consequences of the human chromosomal translocation by fusion of BCR-ABL coding sequences into the bcr endogenous gene. The chimeric mice generated with the mutant embryonic stem cells systematically develop B-ALL. Using these chimeric mice, we further show that BCR-ABL oncogene does not require the endogenous bcr product in leukemogenesis. Our results show that BCR-ABLp190 chimeric mice are a new model to study the biology of the BCR-ABL oncogene and indicate the efficacy of this strategy for studying the role of specific chromosome abnormalities in tumor development.
Blood, Vol. 90 No. 6 (September 15), 1997:
pp. 2168-2174
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. Kavalerchik, D. Goff, and C. H.M. Jamieson
Chronic Myeloid Leukemia Stem Cells
J. Clin. Oncol.,
June 10, 2008;
26(17):
2911 - 2915.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Perez-Mancera, C. Bermejo-Rodriguez, I. Gonzalez-Herrero, M. Herranz, T. Flores, R. Jimenez, and I. Sanchez-Garcia
Adipose tissue mass is modulated by SLUG (SNAI2)
Hum. Mol. Genet.,
December 1, 2007;
16(23):
2972 - 2986.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Calabretta and D. Perrotti
The biology of CML blast crisis
Blood,
June 1, 2004;
103(11):
4010 - 4022.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. McCormick and R. Kavet
Animal Models for the Study of Childhood Leukemia: Considerations for Model Identification and Optimization to Identify Potential Risk Factors
International Journal of Toxicology,
May 1, 2004;
23(3):
149 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ladanyi
Aberrant ALK Tyrosine Kinase Signaling : Different Cellular Lineages, Common Oncogenic Mechanisms?
Am. J. Pathol.,
August 1, 2000;
157(2):
341 - 345.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cobaleda, N. Gutierrez-Cianca, J. Perez-Losada, T. Flores, R. Garcia-Sanz, M. Gonzalez, and I. Sanchez-Garcia
A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia
Blood,
February 1, 2000;
95(3):
1007 - 1013.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
